In lung cancer, for instance, we previously reported that SKP2 was amplified in a homogenous pattern in small cell carcinoma4, but in non-small cell lung carcinoma (NSCLC), a lower SKP2 copy number gain was necessary to influence metastasis5. This evidence concerns the gene SKP2 and non-small cell lung carcinoma.